v3.26.3
Cash, Cash Equivalents, Restricted Cash and Short-term Investments (Tables)
9 Months Ended
Sep. 30, 2026
Cash and Cash Equivalents [Abstract]  
Schedule of Cash and Cash Equivalents
The following table disaggregates the Company’s cash, cash equivalents and restricted cash, which reconciles to the total shown on the Condensed Consolidated Statements of Cash Flows:
September 30,
20262025
Cash and Cash Equivalents$428,199 $444,672 
Restricted Cash—Current (a)
38,242 42,036 
Restricted Cash—Noncurrent (a)
135,134 124,873 
Cash, Cash Equivalents and Restricted Cash$601,575 $611,581 
(a) Restricted Cash—Current and Restricted Cash—Noncurrent are included in Other Current Assets and Funds for Asset Retirement Obligations, respectively, in the accompanying Condensed Consolidated Balance Sheets.
Schedule of Restricted Cash
The following table disaggregates the Company’s cash, cash equivalents and restricted cash, which reconciles to the total shown on the Condensed Consolidated Statements of Cash Flows:
September 30,
20262025
Cash and Cash Equivalents$428,199 $444,672 
Restricted Cash—Current (a)
38,242 42,036 
Restricted Cash—Noncurrent (a)
135,134 124,873 
Cash, Cash Equivalents and Restricted Cash$601,575 $611,581 
(a) Restricted Cash—Current and Restricted Cash—Noncurrent are included in Other Current Assets and Funds for Asset Retirement Obligations, respectively, in the accompanying Condensed Consolidated Balance Sheets.
Schedule Available-for-Sale Investments
The Company’s available-for-sale investments were as follows:
September 30, 2026
Amortized CostAllowance for Credit LossesGross Unrealized
GainsLossesFair Value
Fixed Income Investments$15,847 $— $— $(174)$15,673